Shares of GSK, the multinational healthcare company, experienced a notable increase, marking seven consecutive sessions of gains. On Friday, the stock climbed by 1.7%, reaching a...
GSK plc has secured exclusive worldwide rights from Syndivia to develop and commercialize a preclinical antibody-drug conjugate (ADC) aimed at treating metastatic castration-resistant prostate cancer (mCRPC)....
British pharmaceutical giant GSK announced that its current CEO, Emma Walmsley, will step down after nearly nine years in the role. She will be succeeded by...
GSK (NYSE: GSK) is actively negotiating with the U.S. government to explore options for reducing drug prices. This initiative comes as part of a broader response...
GlaxoSmithKline (GSK) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has extended the review period for its blood cancer therapy, Blenrep. This development...
